October 13, 2022 Epicrispr Biotechnologies Presents Proprietary Gene Expression Modulation System (GEMS) Demonstrating Precise Engineering of DUX4 Gene in Facioscapulohumeral Muscular Dystrophy
October 6, 2022 Epicrispr Biotechnologies to Participate in the Solebury / BMO Fall Private Company Showcase
July 12, 2022 Epicrispr Biotechnologies, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine with Epigenetic Engineering
